Axonal regeneration and sprouting as a potential therapeutic target for nervous system disorders

被引:29
|
作者
Marshall, Katherine L. [1 ]
Farah, Mohamed H. [1 ]
机构
[1] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA
关键词
amyotrophic lateral sclerosis; axonal regeneration; dying-back axonopathy; in vitro neuromuscular junction; iPSC-derived motor neurons; microfluidic device; motor axon sprouting; AMYOTROPHIC-LATERAL-SCLEROSIS; TERMINAL SCHWANN-CELLS; PLACEBO-CONTROLLED TRIAL; NEUROMUSCULAR-JUNCTION; SKELETAL-MUSCLE; MOTOR-NEURONS; SPINAL-CORD; MOUSE MODEL; MOLECULAR-MECHANISMS; HUNTINGTONS-DISEASE;
D O I
10.4103/1673-5374.308077
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Nervous system disorders are prevalent health issues that will only continue to increase in frequency as the population ages. Dying-back axonopathy is a hallmark of many neurologic diseases and leads to axonal disconnection from their targets, which in turn leads to functional impairment. During the course of many of neurologic diseases, axons can regenerate or sprout in an attempt to reconnect with the target and restore synapse function. In amyotrophic lateral sclerosis (ALS), distal motor axons retract from neuromuscular junctions early in the disease-course before significant motor neuron death. There is evidence of compensatory motor axon sprouting and reinnervation of neuromuscular junctions in ALS that is usually quickly overtaken by the disease course. Potential drugs that enhance compensatory sprouting and encourage reinnervation may slow symptom progression and retain muscle function for a longer period of time in ALS and in other diseases that exhibit dying-back axonopathy. There remain many outstanding questions as to the impact of distinct disease-causing mutations on axonal outgrowth and regeneration, especially in regards to motor neurons derived from patient induced pluripotent stem cells. Compartmentalized microfluidic chambers are powerful tools for studying the distal axons of human induced pluripotent stem cells-derived motor neurons, and have recently been used to demonstrate striking regeneration defects in human motor neurons harboring ALS disease-causing mutations. Modeling the human neuromuscular circuit with human induced pluripotent stem cells-derived motor neurons will be critical for developing drugs that enhance axonal regeneration, sprouting, and reinnervation of neuromuscular junctions. In this review we will discuss compensatory axonal sprouting as a potential therapeutic target for ALS, and the use of compartmentalized microfluidic devices to find drugs that enhance regeneration and axonal sprouting of motor axons.
引用
收藏
页码:1901 / 1910
页数:10
相关论文
共 50 条
  • [1] Axonal regeneration and sprouting as a potential therapeutic target for nervous system disorders
    Katherine L. Marshall
    Mohamed H. Farah
    Neural Regeneration Research, 2021, 16 (10) : 1901 - 1910
  • [2] The potential of Slit2 as a therapeutic target for central nervous system disorders
    Sherchan, Prativa
    Travis, Zachary D.
    Tang, Jiping
    Zhang, John H.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (08) : 805 - 818
  • [3] The lymphatic system: a therapeutic target for central nervous system disorders
    Xu, Jia-Qi
    Liu, Qian-Qi
    Huang, Sheng-Yuan
    Duan, Chun-Yue
    Lu, Hong-Bin
    Cao, Yong
    Hu, Jian-Zhong
    NEURAL REGENERATION RESEARCH, 2023, 18 (06) : 1249 - 1256
  • [4] The lymphatic system:a therapeutic target for central nervous system disorders
    Jia-Qi Xu
    Qian-Qi Liu
    Sheng-Yuan Huang
    Chun-Yue Duan
    Hong-Bin Lu
    Yong Cao
    Jian-Zhong Hu
    NeuralRegenerationResearch, 2023, 18 (06) : 1249 - 1256
  • [5] Microglia as therapeutic target in central nervous system disorders
    Fatoba, Oluwaseun
    Itokazu, Takahide
    Yamashita, Toshihide
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2020, 144 (03) : 102 - 118
  • [6] Axonal regeneration in the central nervous system
    So, K. -F.
    NEUROSIGNALS, 2006, 15 (03) : 113 - 113
  • [7] Axonal regeneration in the central nervous system
    Kabiraj, M
    SAUDI MEDICAL JOURNAL, 2002, 23 (10) : 1298 - 1298
  • [8] A POTENTIAL FOR AXONAL REGENERATION IN NEURONS OF THE ADULT MAMMALIAN NERVOUS-SYSTEM
    AGUAYO, AJ
    BENFEY, M
    DAVID, S
    BIRTH DEFECTS-ORIGINAL ARTICLE SERIES, 1983, 19 (04) : 327 - 340
  • [9] Sigma-2 receptor as a potential therapeutic target for treating central nervous system disorders
    Terada, Kazuki
    Migita, Keisuke
    Matsushima, Yukari
    Kamei, Chiaki
    NEURAL REGENERATION RESEARCH, 2019, 14 (11) : 1893 - 1894
  • [10] Sigma-2 receptor as a potential therapeutic target for treating central nervous system disorders
    Kazuki Terada
    Keisuke Migita
    Yukari Matsushima
    Chiaki Kamei
    Neural Regeneration Research, 2019, 14 (11) : 1893 - 1894